| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 12.41B | 7.39B | 6.43B | 5.76B | 3.59B |
| Gross Profit | 1.47B | 1.08B | 906.54M | 624.66M | 583.36M |
| EBITDA | 1.04B | 710.55M | 647.21M | 325.99M | 345.10M |
| Net Income | 783.68M | 450.87M | 369.52M | 215.14M | 168.22M |
Balance Sheet | |||||
| Total Assets | 9.17B | 5.03B | 6.16B | 6.11B | 3.18B |
| Cash, Cash Equivalents and Short-Term Investments | 1.54B | 425.85M | 378.35M | 1.26B | 247.21M |
| Total Debt | 3.54B | 1.45B | 3.63B | 3.38B | 1.12B |
| Total Liabilities | 6.34B | 3.25B | 4.79B | 4.96B | 2.12B |
| Stockholders Equity | 2.83B | 1.77B | 1.36B | 1.13B | 1.05B |
Cash Flow | |||||
| Free Cash Flow | 517.50M | 868.29M | 900.88M | -1.70B | 113.77M |
| Operating Cash Flow | 664.51M | 1.05B | 981.37M | -1.49B | 173.12M |
| Investing Cash Flow | -178.95M | 673.43M | -41.55M | -2.31B | -110.96M |
| Financing Cash Flow | -151.86M | -1.65B | -901.37M | 3.83B | -45.12M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | HK$2.28T | 29.45 | 22.82% | 0.21% | 30.08% | ― | |
74 Outperform | HK$42.50B | 17.74 | 22.19% | 0.17% | 67.95% | 73.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
54 Neutral | HK$52.57B | ― | 1.78% | ― | 60.41% | 150.51% | |
52 Neutral | HK$1.41B | -2.34 | -3.73% | 6.40% | -34.79% | -130.42% | |
51 Neutral | HK$455.61M | -1.78 | -16.83% | ― | -15.04% | 71.02% | |
43 Neutral | HK$190.98M | -18.54 | -6.19% | ― | 5.07% | 28.18% |